Pitfalls of retrospective and nonrandomized comparison of treatment modalities

Journal of Clinical Oncology

Volumn 28, Issue 28, 2010, Pages

  Sandhu, Ajay P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LETTER; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ADENOCARCINOMA; METASTASIS; METHODOLOGY; NOTE; PATHOLOGY; PROSTATE TUMOR; SALVAGE THERAPY;

ADENOCARCINOMA; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; RESEARCH DESIGN; SALVAGE THERAPY;

EID: 78049429935     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.5352     Document Type: Letter

References (2)

1. Zelefsky MJ, Eastham JA, Cronin AM, et al: Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: A comparison of clinical cohorts adjusted for case mix. J Clin Oncol 28:1508-1513, 2010
2. Thompson IM, Tangen CM, Paradelo J, et al: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term followup of a randomized clinical trial. J Urol 181:956-962, 2009